#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	16154	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2113	759.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1405	1405	C	927	C	865	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29230	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3481	836.8	0	.	n	.	0	T695C	SNP	695	695	T	958	958	C	888	C,T	818,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29230	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3481	836.8	0	.	n	.	0	G1337A	SNP	1337	1337	G	1600	1600	A	1024	A,G	961,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29230	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3481	836.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2234	2234	C	945	C,T	874,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29230	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3481	836.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2308	2308	A	986	A	915	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29230	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3481	836.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	2860	2860	C	915	C,T,G	861,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	2254	folP	852	852	100.0	folP.l15.c30.ctg.1	1547	145.4	1	SNP	p	R228S	1	.	.	682	684	AGC	1014	1016	AGC	243;240;240	A;G;C	230;228;228	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6190	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3465	178.1	1	SNP	p	S91F	0	.	.	271	273	TCC	666	668	TCC	217;219;220	T;C;C	203;206;208	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6190	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3465	178.1	1	SNP	p	D95N	0	.	.	283	285	GAC	678	680	GAC	219;223;220	G;A;C	206;211;209	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6190	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3465	178.1	1	SNP	p	D95G	0	.	.	283	285	GAC	678	680	GAC	219;223;220	G;A;C	206;211;209	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_U_01459	mtrR.WHO_U_01459	1	1	539	1322	mtrR	633	633	97.47	mtrR.l15.c17.ctg.1	1283	102.6	0	.	p	.	0	D79N	NONSYN	235	237	GAT	533	535	AAT	195;192;190	A,G;A;T	180,1;180;179	.	.
mtrR.WHO_U_01459	mtrR.WHO_U_01459	1	1	539	1322	mtrR	633	633	97.47	mtrR.l15.c17.ctg.1	1283	102.6	0	.	p	.	0	A86T	NONSYN	256	258	GCG	554	556	ACG	213;211;213	A;C;G	192;193;195	.	.
mtrR.WHO_U_01459	mtrR.WHO_U_01459	1	1	539	1322	mtrR	633	633	97.47	mtrR.l15.c17.ctg.1	1283	102.6	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	611	613	CAC	193;194;195	C;A;C	179;176;181	.	.
mtrR.WHO_U_01459	mtrR.WHO_U_01459	1	1	539	1322	mtrR	633	633	97.47	mtrR.l15.c17.ctg.1	1283	102.6	0	.	p	.	0	S183N	NONSYN	547	549	AGT	845	847	AAT	86;86;85	A;A;T	84;85;84	.	.
mtrR.WHO_U_01459	mtrR.WHO_U_01459	1	1	539	1322	mtrR	633	633	97.47	mtrR.l15.c17.ctg.1	1283	102.6	0	.	p	.	0	M197I	NONSYN	589	591	ATG	887	889	ATA	80;81;81	A;T;A	73;73;74	.	.
mtrR.WHO_U_01459	mtrR.WHO_U_01459	1	1	539	1322	mtrR	633	633	97.47	mtrR.l15.c17.ctg.1	1283	102.6	1	SNP	p	G45D	0	.	.	133	135	GGC	431	433	GGC	202;202;202	G;G;C	183;183;184	mtrR.WHO_U_01459:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5980	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2907	204.9	1	SNP	p	D86N	0	.	.	256	258	GAC	535	537	GAC	221;223;222	G;A;C	204;202;209	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5980	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2907	204.9	1	SNP	p	S87I	0	.	.	259	261	AGT	538	540	AGT	225;225;227	A;G;T	210;209;208	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5980	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2907	204.9	1	SNP	p	S87R	0	.	.	259	261	AGT	538	540	AGT	225;225;227	A;G;T	210;209;208	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5980	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2907	204.9	1	SNP	p	S87W	0	.	.	259	261	AGT	538	540	AGT	225;225;227	A;G;T	210;209;208	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5980	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2907	204.9	1	SNP	p	S88P	0	.	.	262	264	TCC	541	543	TCC	228;231;228	T;C;C	210;215;216	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4952	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2579	191.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1520	1522	GGC	239;242;238	G;G;C	228;225;224	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	4498	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2403	186.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1288	1290	GCA	274;277;279	G;C;A,C	258;257;261,1	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4498	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2403	186.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1291	1293	ATC	279;283;286	A;T;C,G	260;264;265,1	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4498	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2403	186.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1303	1305	GTG	285;283;285	G;T;G	262;258;261	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4498	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2403	186.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1303	1305	GTG	285;283;285	G;T;G	262;258;261	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4498	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2403	186.1	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1807	1809	ACC	233;231;229	A;C;C	205;208;208	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4498	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2403	186.1	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1861	1863	GCG	202;199;201	G,A;C;G	180,1;160;169	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4498	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2403	186.1	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1861	1863	GCG	202;199;201	G,A;C;G	180,1;160;169	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4498	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2403	186.1	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1984	1986	GGC	209;206;207	G;G;C	191;186;187	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4498	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2403	186.1	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1993	1995	GGC	205;204;206	G;G;C	183;184;184	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4498	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2403	186.1	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2011	2013	CCG	185;187;187	C,G;C,G;G,A	132,8;133,2;133,1	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6348	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3172	199.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2740	porA	1146	1146	99.83	porA.l6.c4.ctg.1	1758	155.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	515	515	C	177	C	163	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3292	porB1b	1038	1038	98.38	porB1b.l6.c4.ctg.1	1509	217.2	0	.	p	.	0	I45V	NONSYN	133	135	ATT	378	380	GTT	291;291;290	G,A;T;T	270,1;267;272	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3292	porB1b	1038	1038	98.38	porB1b.l6.c4.ctg.1	1509	217.2	0	.	p	.	0	I75V	NONSYN	223	225	ATT	468	470	GTT	276;278;280	G;T;T	252;247;259	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3292	porB1b	1038	1038	98.38	porB1b.l6.c4.ctg.1	1509	217.2	0	.	p	.	0	S89T	NONSYN	265	267	AGC	510	512	ACC	288;288;289	A,C;C,A;C	258,1;269,1;269	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3292	porB1b	1038	1038	98.38	porB1b.l6.c4.ctg.1	1509	217.2	0	.	p	.	0	I98V	NONSYN	292	294	ATC	537	539	GTC	275;275;272	G,T;T;C	243,1;243;249	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3292	porB1b	1038	1038	98.38	porB1b.l6.c4.ctg.1	1509	217.2	0	.	p	.	0	Y213_N214insRYAY	INS	637	637	T	882	882	T	300	T	284	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3292	porB1b	1038	1038	98.38	porB1b.l6.c4.ctg.1	1509	217.2	1	SNP	p	G120K	1	.	.	358	360	AAG	603	605	AAG	270;268;266	A;A;G	258;257;256	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3292	porB1b	1038	1038	98.38	porB1b.l6.c4.ctg.1	1509	217.2	1	SNP	p	A121N	1	.	.	361	363	AAC	606	608	AAC	266;263;264	A;A;C	256;254;254	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3292	porB1b	1038	1038	98.38	porB1b.l6.c4.ctg.1	1509	217.2	1	SNP	p	N121D	0	.	.	361	363	AAC	606	608	AAC	266;263;264	A;A;C	256;254;254	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11828	rpoB	4179	4179	100.0	rpoB.l6.c30.ctg.1	4862	242.5	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2049	2051	AAT	275;273;272	A;A;T	256;255;255	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1272	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	921	136.9	1	SNP	p	V57M	1	.	.	169	171	ATG	434	436	ATG	281;285;285	A;T;G	262;263;265	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
